Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Cost of Revenue (2020 - 2025)

Agilon Health (AGL) has disclosed Cost of Revenue for 6 consecutive years, with -$88.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 162.71% year-over-year to -$88.8 million, compared with a TTM value of $7.0 million through Dec 2025, down 98.78%, and an annual FY2025 reading of $7.0 million, down 96.72% over the prior year.
  • Cost of Revenue was -$88.8 million for Q4 2025 at Agilon Health, down from $13.5 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $566.2 million in Q1 2022 and bottomed at -$404.6 million in Q4 2022.
  • Average Cost of Revenue over 5 years is $138.0 million, with a median of $64.9 million recorded in 2023.
  • The sharpest move saw Cost of Revenue plummeted 388.4% in 2022, then skyrocketed 1888.85% in 2023.
  • Year by year, Cost of Revenue stood at $140.3 million in 2021, then tumbled by 388.4% to -$404.6 million in 2022, then surged by 169.88% to $282.7 million in 2023, then tumbled by 49.89% to $141.7 million in 2024, then crashed by 162.71% to -$88.8 million in 2025.
  • Business Quant data shows Cost of Revenue for AGL at -$88.8 million in Q4 2025, $13.5 million in Q3 2025, and $46.1 million in Q2 2025.